Geode Capital Management, LLC Athenex, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.12 - $0.21 $150 - $264	-1,258 Reduced 0.22%	560,382 $82,000
Q2 2022 Aug 12, 2022	SELL	$0.41 - $0.91 $281,538 - $624,878	-686,680 Reduced 55.01%	561,640 $229,000
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $54,616 - $109,924	-69,135 Reduced 5.25%	1,248,320 $1.04 Million
Q4 2021 Feb 11, 2022	SELL	$1.36 - $2.94 $62,785 - $135,728	-46,166 Reduced 3.39%	1,317,455 $1.79 Million
Q3 2021 Nov 12, 2021	SELL	$2.97 - $4.84 $12,093 - $19,708	-4,072 Reduced 0.3%	1,363,621 $4.1 Million
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.13 $472,806 - $653,772	127,441 Added 10.28%	1,367,693 $6.32 Million
Q1 2021 May 12, 2021	BUY	$4.08 - $14.75 $363,275 - $1.31 Million	89,038 Added 7.73%	1,240,252 $5.33 Million
Q4 2020 Feb 12, 2021	BUY	$11.06 - $14.01 $2.22 Million - $2.81 Million	200,688 Added 21.11%	1,151,214 $12.7 Million
Q3 2020 Nov 13, 2020	BUY	$10.26 - $14.55 $43,820 - $62,143	4,271 Added 0.45%	950,526 $11.5 Million
Q2 2020 Aug 13, 2020	BUY	$7.11 - $13.76 $441,680 - $854,784	62,121 Added 7.03%	946,255 $13 Million
Q1 2020 May 14, 2020	BUY	$5.71 - $15.85 $509,805 - $1.42 Million	89,283 Added 11.23%	884,134 $6.84 Million
Q4 2019 Feb 13, 2020	BUY	$9.6 - $17.75 $443,856 - $820,671	46,235 Added 6.18%	794,851 $12.1 Million
Q3 2019 Nov 12, 2019	SELL	$12.16 - $21.0 $51,521 - $88,977	-4,237 Reduced 0.56%	748,616 $9.11 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $2.05 Million - $4.3 Million	217,350 Added 40.59%	752,853 $14.9 Million
Q1 2019 May 14, 2019	BUY	$11.11 - $13.49 $509,249 - $618,341	45,837 Added 9.36%	535,503 $6.56 Million
Q4 2018 Feb 13, 2019	BUY	$10.24 - $15.49 $359,024 - $543,094	35,061 Added 7.71%	489,666 $6.21 Million
Q3 2018 Nov 13, 2018	BUY	$15.53 - $19.97 $792,418 - $1.02 Million	51,025 Added 12.64%	454,605 $7.06 Million
Q2 2018 Aug 14, 2018	BUY	$15.88 - $19.5 $1.62 Million - $1.99 Million	102,105 Added 33.87%	403,580 $7.53 Million
Q1 2018 May 15, 2018	BUY	$13.53 - $17.47 $2.5 Million - $3.23 Million	184,666 Added 158.09%	301,475 $5.13 Million
Q4 2017 Feb 13, 2018	BUY	$14.41 - $19.15 $386,663 - $513,851	26,833 Added 29.82%	116,809 $1.86 Million
Q3 2017 Nov 14, 2017	BUY	$13.5 - $19.51 $1.21 Million - $1.76 Million	89,976	89,976 $1.58 Million

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account